Inovio Pharmaceuticals(DE:GBM)
€1.50+0.05 (+3.30%)
DE:GBM
Inovio Pharmaceuticals earnings date
€1.50
At close:+0.05 (+3.30%)
Inovio Pharmaceuticals (GBM) Q4 2023 Earnings Report
6 Followers
DE:GBM Q4 2023 EPS Results
- Actual EPS
- -EUR 1.00
- Consensus EPS
- -EUR 1.08
- Beat/Miss
- Beat by +EUR 0.08
- One Year Ago EPS
- -EUR 2.41
DE:GBM Q4 2023 Revenue Results
- Actual Revenue
- EUR 93.57K
- Expected Revenue
- EUR 328.17K
- Beat/Miss
- Missed by -EUR 234.59K
- YoY Revenue Growth
- -17.66%
Earnings Announcement Details
- Quarter
- Q4 2023
- Date
- 03/06/2024
- Time
- After Close
- Conference Call
- Wednesday, March 6, 2024
DE:GBM Upcoming Earnings
Inovio Pharmaceuticals's next earnings date is estimated for March 2, 2027, based on past reporting schedules.
Q4 2023 Earnings Call Audio
DE:GBM Q4 2023 Earnings Call
0:00 / 0:00
Q4 2023 Earnings Slide Deck
No slide deck is available for this earnings event.
Q4 2023 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:GBM Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Mar 02, 2027 | 2026 (Q4) | -0.12- | 0.05 | ― | ― |
| Nov 10, 2026 | 2026 (Q3) | -0.19-0.46 | -0.79 | 42.53% (+0.34) | |
| Aug 12, 2026 | 2026 (Q2) | -0.20-0.06 | -0.56 | 88.52% (+0.49) | |
| May 13, 2026 | 2026 (Q1) | -0.32-0.26 | -0.46 | 45.10% (+0.21) | |
| Mar 12, 2026 | 2025 (Q4) | -0.330.05 | -0.59 | 109.23% (+0.65) | |
| Nov 10, 2025 | 2025 (Q3) | -0.38-0.79 | -0.81 | 2.25% (+0.02) | |
| Aug 12, 2025 | 2025 (Q2) | -0.56-0.56 | -1.08 | 48.74% (+0.53) | |
| May 13, 2025 | 2025 (Q1) | -0.63-0.46 | -1.19 | 61.07% (+0.73) | |
| Mar 18, 2025 | 2024 (Q4) | -0.76-0.59 | -1 | 40.91% (+0.41) | |
| Nov 14, 2024 | 2024 (Q3) | -1.05-0.81 | -1.42 | 42.95% (+0.61) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed

